{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zhang S"],"funding":["The National Natural Science Foundation of China","Ili Kazkh Autonomous Clinical Research Institute"],"pagination":["4018"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10874971"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(1)"],"pubmed_abstract":["The role of ATP6AP1 in colorectal cancer (CRC) remains elusive despite its observed upregulation in pan-cancer. Therefore, the current study aimed to assess the clinical significance of ATP6AP1 and its relationship with the immune infiltration in CRC. Transcriptome data of CRC were obtained from The Cancer Genome Atlas (TCGA) database and analyzed using the combination of R packages and tumor-related databases, including TIMER2, TISIDB, cBioPortal, and MethSurv. The tissue arrays and immunohistochemical staining were performed to verify the expression and clinical characteristics of ATP6AP1. The results revealed that ATP6AP1 expression was significantly elevated in CRC and associated with poor clinicopathological characteristics and prognosis. Furthermore, the analysis demonstrated ATP6AP1"],"journal":["Scientific reports"],"pubmed_title":["ATP6AP1 as a potential prognostic biomarker in CRC by comprehensive analysis and verification."],"pmcid":["PMC10874971"],"funding_grant_id":["yl2020ms10","82000621","82202828"],"pubmed_authors":["Wang M","Fan W","Liu L","Wang B","Tao Y","Zhang X","Gao W","Zhang S","Wang Y","Wu H"],"additional_accession":[]},"is_claimable":false,"name":"ATP6AP1 as a potential prognostic biomarker in CRC by comprehensive analysis and verification.","description":"The role of ATP6AP1 in colorectal cancer (CRC) remains elusive despite its observed upregulation in pan-cancer. Therefore, the current study aimed to assess the clinical significance of ATP6AP1 and its relationship with the immune infiltration in CRC. Transcriptome data of CRC were obtained from The Cancer Genome Atlas (TCGA) database and analyzed using the combination of R packages and tumor-related databases, including TIMER2, TISIDB, cBioPortal, and MethSurv. The tissue arrays and immunohistochemical staining were performed to verify the expression and clinical characteristics of ATP6AP1. The results revealed that ATP6AP1 expression was significantly elevated in CRC and associated with poor clinicopathological characteristics and prognosis. Furthermore, the analysis demonstrated ATP6AP1","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Feb","modification":"2025-04-04T14:00:58.539Z","creation":"2025-04-04T14:00:58.539Z"},"accession":"S-EPMC10874971","cross_references":{"pubmed":["38369634"],"doi":["10.1038/s41598-024-54437-7"]}}